Oisin Biotechnologies (Series A)
Funding Details
- Awarder
- RSS - www.geekwire.com
- Date Award
- August 02, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $15,000,000
Company Info
- Founding Year
- 2016
- Founders
- Matthew Scholz, John Lewis, Gary Hudson
- Company Description
- Oisin Biotechnologies is a drug development company focused on mitigating the senolytic technology to combat age-related diseases.
- Market
- Health
- Location
- Seattle, WA, US
- Coinvestors
- AbbVie Ventures